Tag: drug discovery

Actithera Raises $75.5M in Oversubscribed Series A Financing to Redefine Precision Radioligand Therapy

Series A co-led by founding investor M Ventures and new lead investors Hadean Ventures, Sofinnova Partners, and 4BIO Capital with syndicate including Bioqube Ventures, Surveyor...

Biosensors Market worth $54.37 billion by 2030 – Exclusive Report by MarketsandMarkets™

DELRAY BEACH, Fla., July 8, 2025 /PRNewswire/ -- The global biosensors market is projected to grow from USD 34.51 billion in 2025 to USD 54.37...

Biosensors Market worth $54.37 billion by 2030 – Exclusive Report by MarketsandMarkets™

DELRAY BEACH, Fla., July 8, 2025 /PRNewswire/ -- The global biosensors market is projected to grow from USD 34.51 billion in 2025 to USD 54.37...

mRNA Sequencing Market Size to Hit USD 4.02 billion by 2031, Growing at 13.6% CAGR, Benefits from Surging Prevalence of Cancer | The Insight...

NEW YORK, July 7, 2025 /PRNewswire/ -- According to a new comprehensive report from The Insight Partners, the global mRNA sequencing market is observing...

Analyzing CEO Insights: Stripe and Skip’s Influence on Algorithmic Market Dynamics

Patrick Collison, CEO of Stripe, and Kathryn Zealand, CEO of Skip, recently joined a discussion focused on the intersection of technology and societal advancement....

HotSpot Therapeutics Presents Preclinical Data from Small Molecule CBM Signalosome Inhibitor Program at ESMO Gastrointestinal Cancers Congress 2025

BOSTON, July 4, 2025 /PRNewswire/ -- HotSpot Therapeutics, Inc., a biotechnology company pioneering the discovery and development of oral, small molecule allosteric therapies targeting Smart...

HitGen Releases Its Inaugural Sustainability Report

CHENGDU, China, July 4, 2025 /PRNewswire/ -- Shanghai Stock Exchange listed company HitGen Inc. ("HitGen", SSE: 688222.SH) today announced the release of its inaugural...

ESG | HitGen Releases Its Inaugural Sustainability Report

CHENGDU, China, July 4, 2025 /PRNewswire/ -- Shanghai Stock Exchange listed company HitGen Inc. ("HitGen", SSE: 688222.SH) today announced the release of its inaugural sustainability...

Monte Rosa Announces Publication in Science of Key Insights that Enable Next Generation Molecular Glue Degrader Medicines

Jacobio’s IND for Phase I/II Clinical Trial of BET Inhibitor JAB-8263 in Autoimmune Diseases has been Accepted

BEIJING, SHANGHAI and BOSTON, July 2, 2025 /PRNewswire/ -- Jacobio Pharma (1167.HK) announced that it has submitted the Phase I/II Investigational New Drug (IND)...

Ascletis Announces First Participants with Obesity or Overweight Dosed in a U.S. 13-week Phase IIa Study of Small Molecule Oral GLP-1R Agonist ASC30

- First participants with obesity or overweight with at least one weight-related comorbidity have been dosed in a U.S. 13-week Phase IIa study of...

Cellectar Biosciences Announces Pricing of $6 Million Underwritten Public Offering

FLORHAM PARK, N.J., July 01, 2025 (GLOBE NEWSWIRE) -- Cellectar Biosciences, Inc. (Nasdaq: CLRB) (the “Company”), a late-stage clinical biopharmaceutical company focused on the discovery and development of drugs for the treatment of cancer, today announced the pricing of an underwritten public offering for gross proceeds of approximately $6 million prior to deducting underwriting commissions and offering expenses.

Frontage Announces Expansion of Business in Canada with New Leadership

EXTON, Pa., July 1, 2025 /PRNewswire/ -- As part of the strategy in expanding service offerings across the globe, Frontage Holdings Corporation is pleased...

atai Life Sciences Announces $50 Million Private Placement Financing

Financing co-led by Ferring Ventures S.A. and Apeiron Investment Ltd. with participation from new and existing healthcare-focused institutional investors, including Ally Bridge Group and ADAR1

Financing co-led by Ferring Ventures S.A. and Apeiron Investment Ltd. with participation from new and existing healthcare-focused institutional investors, including Ally Bridge Group and ADAR1

- A word from our sponsors -

Newsletter Signup

Name(Required)

First Last

Company Name

Email(Required)

Enter Email Confirm Email

CAPTCHA

Privacy(Required)

I agree with the storage and handling of my data by this website. - Privacy Policy *

Phone

This field is for validation purposes and should be left unchanged.

HomeTagsDrug discovery

Oma Säästöpankki Oyj:n osakkeenomistajien nimitystoimikunnan kokoonpano

Baseload Power Taiwan and CPC Corporation, Taiwan sign MOU to advance geothermal development

HSBC AND GOOGLE CLOUD ANNOUNCE TRANSFORMATIVE AI BANKING PARTNERSHIP

Tag: drug discovery

Actithera Raises $75.5M in Oversubscribed Series A Financing to Redefine Precision Radioligand Therapy

Biosensors Market worth $54.37 billion by 2030 – Exclusive Report by MarketsandMarkets™

Biosensors Market worth $54.37 billion by 2030 – Exclusive Report by MarketsandMarkets™

mRNA Sequencing Market Size to Hit USD 4.02 billion by 2031, Growing at 13.6% CAGR, Benefits from Surging Prevalence of Cancer | The Insight...

Analyzing CEO Insights: Stripe and Skip’s Influence on Algorithmic Market Dynamics

HotSpot Therapeutics Presents Preclinical Data from Small Molecule CBM Signalosome Inhibitor Program at ESMO Gastrointestinal Cancers Congress 2025

HitGen Releases Its Inaugural Sustainability Report

ESG | HitGen Releases Its Inaugural Sustainability Report

Monte Rosa Announces Publication in Science of Key Insights that Enable Next Generation Molecular Glue Degrader Medicines

Jacobio’s IND for Phase I/II Clinical Trial of BET Inhibitor JAB-8263 in Autoimmune Diseases has been Accepted

Ascletis Announces First Participants with Obesity or Overweight Dosed in a U.S. 13-week Phase IIa Study of Small Molecule Oral GLP-1R Agonist ASC30

Cellectar Biosciences Announces Pricing of $6 Million Underwritten Public Offering

Frontage Announces Expansion of Business in Canada with New Leadership

atai Life Sciences Announces $50 Million Private Placement Financing

Newsletter Signup

Explore

Press Releases

News & Opinion

Living

Others

Follow us